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Abstract 
 
The ease of fabrication and integration of pneumatic microvalves has enabled extensive 
miniaturization of microfluidic devices that are capable of performing massively parallel 
operations.  These valves in their typical open configuration, also known as normally open (NO) 
valves, require to be actuated to remain closed.  As a result, devices employing these valves have 
limited portability in applications that require valves to be closed continuously.  Normally closed 
(NC) valves based on pneumatic actuation not only address the above issue of portability, but 
also retain the ease of integrating massively parallel networks of microfluidic elements.  In this 
thesis, I report the design, fabrication, and application of elastomeric NC microvalves, along 
with systematic experimental characterization of NC valve operation.  Geometrical parameters of 
the valve, including shape, fluid channel width, membrane thickness, and valve asymmetry were 
examined with the objective of minimizing actuation pressures and ensuring reliable operation.  I 
observed that introduction of asymmetry in the valve geometry created points of weak adhesion 
between the valve and the substrate, which facilitated opening of the valve at lower actuation 
pressures.  Specifically, valves with a sharp corner feature (v-shaped) actuated at lower pressures 
(1.5 psi) compared to straight-shaped valves (3 psi).  I also observed that membrane thickness 
does not significantly influence the actuation pressures.  An important requirement for 
microfluidic devices using NC valves is selective irreversible bonding of the fluid layer to the 
substrate, which I achieved by plasma sealing of the fluid layer to the substrate while 
simultaneously actuating the valves.  Based on our experimental observations, I formulated a set 
of design considerations with the objective of minimizing actuation pressures, ensuring reliable 
operation, and facilitating convenient integration into complex microfluidic devices.  These NC 
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valves have significant potential in applications where portability is highly desired, such as in 
on-chip analysis, crystallization screening, and in the study of chemical or biological processes 
over long durations of time.  I utilized these optimized design considerations to fabricate a 4x6 
multiplexed microfluidic platform capable of combinatorial exposure of bacterial cells (E. coli) 
to diverse metabolites such as toxins, hormones, and antibiotics.  I validated these chips for 
biological applications first by studying cell growth, and then demonstrated the multiplexing 
capabilities with inducible expression of the Green Florescent Protein (GFP) gene in E. coli cells 
on-chip using different concentrations of isopropyl β-D-1-thiogalactopyranoside  (IPTG).  The 
key application of the platform is its utilization in antibiotic susceptibility screening.   
Keywords: Microvalves; soft lithography; actuation pressure; hysteresis; normally closed valves; 
antibiotics; Green Florescent Protein (GFP); isopropyl β-D-1-thiogalactopyranoside  (IPTG) 
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Chapter 1 
Introduction 
1.1 Integrated Microchemical Systems 
Widespread use of microfabrication techniques have resulted in integrated microsystems 
in applications beyond electronic circuits (1), e.g. integrated systems in chemistry or 
microchemical systems.  These microfluidic systems typically consist of many components, such 
as sensors, actuators, mixers (2), pumps (3), reactors (4-7), heat exchangers (5, 8, 9), and 
separation units (10-12), with sizes ranging from tens of microns to hundreds of microns.  The 
reduction in size of various components and integration of multiple functions on a single 
microfluidic device has led to capabilities exceeding those possible at macro scale.  For example, 
in conventional techniques for cell studies, the transition from 384 to 1536 plates is a challenge, 
most likely due to edge effects caused due to differences between the environments of cells at the 
edge and at the center of the plates, and uncontrolled evaporation from very small wells, which 
results in poor culture conditions (13).  Such effects are negligible in high throughput 
microfluidics. In literature, a broad range of microchemical systems have been reported, which 
have been used in diverse set of applications, ranging from on-chip DNA analysis, 
immunoassays and cytometry (14-18) to integrated detection technologies such as biosensors 
(19, 20) and micro-fuel cell applications (21-27).   
In microfluidics, currently the biggest challenge is the ability to integrate all the 
components on-chip, so that one can execute complex chemical reactions and also perform 
massively parallel operations.  Several of these applications require multiple reactions to be 
performed in parallel, because reagents can be expensive or available only in small amounts (28).  
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Along with integration of many components in a “lab-on-chip” format, another challenge is the 
limited portability of these devices.  Such densely integrated portable microchemical systems are 
promising in biomedical and pharmaceutical research, since microfluidic devices that are robust 
and portable can be used in clinical settings for both developing and developed countries (13). 
For precise control and manipulation of various chemical and biological reagents where 
small volumes of fluids (picoliters to nanoliters) need to be manipulated mixed, fine control for 
fluid routing is a requirement (29-32).  In almost all the devices, the integrated microchemical 
system relies on directing flow of chemical reagents from one component to another.  While 
some microfluidic devices rely on continuous flow from one chamber to another, many others 
require more complex routing.  Therefore, microvalves that route flow are probably one of the 
most important components in these microfluidic devices (30, 31, 33, 34).  Along with research 
on different microfluidic components such as micropumps, and micromixers, significant efforts 
are required for development for microvalves.  
 
1.2 Microvalves for Integrated Microchemical Systems 
An ideal microvalve should comprise several desirable characteristics for their integration 
into microchemical systems.  Amongst many ideal characteristics, the most important one is easy 
fabrication and integration into microfluidic devices.  Although significant progress has been 
made in improving the performance of valves with respect to their response time, leakage, dead 
volume, power consumption, sensitivity to particulate contamination, and chemical 
compatibility, further improvements in design and fabrication of the microvalves to incorporate 
all the ideal characteristics are needed (36, 37). 
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Microvalves can be categorized into two types: (a) active microvalves (b) passive 
microvalves, both using mechanical and non-mechanical moving parts, and active microvalves 
utilizing external systems as well.  Mechanical active microvalves are generally fabricated using 
MEMS-based bulk or surface micromachining technologies, in which the mechanically movable 
membranes are coupled with magnetic, electric, piezoelectric, or thermal actuation methods.  
Non-mechanical active valves on the other hand utilize smart materials such as rheological 
materials for their actuation.  On one hand, active microvalves usually require external forces for 
their actuation such as pneumatic methods.  Passive microvalves, on the other hand do not 
require any external force for their actuation (36, 38, 39).  Based on whether the microvalve is 
active or passive, the microvalve divided into a normally open or a normally closed valve.  
In the literature, several kinds of microvalves based on different kinds of actuation 
principles have been developed for various applications.  For example, microvalves utilizing 
external magnetic field for their actuation have been used in integrated gas chromatography 
systems, and pressure regulators (40).  Amongst many microvalves utilizing external magnetic 
field, pinch type valves are often favored in microfluidic biochemical detection system for 
magnetic bead immunoassay due to their ability to provide zero leakage flow, zero dead volume, 
fast response, high flow range, and easy replacement of tubing (41, 42).  Microvalves utilizing 
electric force for their actuation such as electrostatic microvalves have also been widely used as 
gas flow regulators (26, 43-45).  Teymoori and Abbaspour-Sani fabricated a peristaltic 
micropump connected serially with electrostatic microvalves for medical applications (45).  
Similarly, several other microvalves utilizing actuation methods such as piezoelectricity, and 
thermal forces have been developed for microfluidic applications.  However, most of the 
microvalves mentioned above and in the literature not only involve difficult fabrication process, 
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but are also not easy to use, and are incompatible with a wide range of chemical environments.  
Thus, there is a need to develop a microfluidic platform utilizing microvalves that are compatible 
with a wide range of chemical stimuli and are easy to fabricate and use.  For instance, 
elastomeric pneumatic microvalves (46) have been successfully used in many applications that 
require multi-step and high throughput operations on a single device (34, 46).  A significant 
advantage of these pneumatic microvalves is that the fabrication of the valves is compatible with 
standard soft lithographic techniques, allowing easy integration of these valves into complex 
microfluidic devices.  Additionally they have small footprint, and are compatible with various 
chemical and biological processes.  
 
1.3 Research Objectives 
In this work, I present design rules for pneumatically actuated Normally Closed (NC) 
microvalve fabricated using standard soft lithography which is discussed in Chapter 2 and its 
application in biological systems Chapter 4.  NC valves have several key advantages over the 
more popular and commonly used pneumatically actuated Normally Open (NO) microvalves in 
the field of microfluidics.  (i) They do not require continuous actuation since they are closed in 
rest position.  (ii)  The need to irreversibly seal the device to the bottom substrate is eliminated 
(iii) Since PDMS is gas permeable,  the need for reagent feed lines when fluids are pipetted on 
fluid inlets  are eliminated, which drastically reduces dead volume.  (iv) NC valve chip is highly 
portable since all the external pneumatic connections can be removed after filling.  (v) NC valve 
chips can have high degree of complexity because valve area overlaps with compartment area 
instead of being located in between compartments (47).  The primary focus of my thesis lies in 
reporting the design rules for these NC microvalves with respect to their integration into 
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microfluidic devices (Chapter 3).  The initial goal is to optimize these NC microvalves with 
respect to various parameters, such as membrane thickness, valve shape, control channel height, 
and geometrical asymmetry with an objective of minimizing actuation pressures.  The 
parameters are carefully chosen based on their sensitivity to affect actuation pressures of the NC 
microvalves.  In addition, another objective is to elucidate optimal operational considerations 
such as valve performance in dense networks, and their actuation in reversibly and irreversibly 
bonded devices.  
The secondary focus of the thesis is to utilize the design rules for fabrication of a 
microfluidic platform for biological applications (Chapter 4).  Specifically, the main objective is 
to screen bacterial cells such as E. coli against diverse antibiotics.  The initial goal is to validate 
the microfluidic platform for biological studies by first quantifying the growth of E. coli cells in 
microchambers.  The next objective is to test the combinatorial capabilities of the platform which 
is done by mixing different concentrations of Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
with “off” E. coli cells.  The “off” cells get turned “on” after a few hours of mixing with IPTG.  
Finally, antibiotic screening testing is performed by testing different concentrations of the 
antibiotic ampicillin with E. coli cells.  Additionally, my aim is also to provide a summary and a 
future direction of my research in chapter 5 and additional information for all my results in 
chapters 6 and 7.  
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Chapter 2 
Design and Fabrication of Normally Closed Microvalve1 
2.1 Introduction 
Pneumatic microvalves can be broadly classified into two types: normally open (NO) and 
normally closed (NC) (1), similar to fail-close and fail-open valve architecture in larger scale 
systems (2).  Although NO valves are widely used in many microfluidic applications (3, 4), 
devices employing these NO valves have limited portability in applications that require 
continuous closed state for operation, as these valves need bulky ancillaries (pumps, nitrogen gas 
cylinders, pneumatic peripherals) to keep the valve closed by actuation.  For example, in our 
investigations on on-chip protein-antibody interactions (5) or virus detection (6), the valves need 
to be open only for a short period of time when the solutions are being introduced and mixed.  
Use of NO valves in these applications would have limited the portability between the mixing 
station and detection ancillaries such as a microscope (5, 6).  NC valves not only address the 
above limitation of restricted portability, but also retain the ease of fabrication and integration 
into microfluidic devices.  Moreover, NO microvalves typically require actuation pressures of 6 
to 30 psi (7, 8), whereas NC valves can be actuated with lower pressures, in the range of 1 to 12 
psi, as demonstrated here and by Grover et al. (9). 
NC valves made out of silicon and glass have been used in several applications, such as 
portable fuel cell systems using piezoelectric valves (10) and bidirectional gas regulators for 
micro-gas chromatography systems (11).  The focus of this chapter will be on NC valves made 
                                                            
1 Part of the work in this chapter has been published:  Mohan R., Schudel B.R., Desai A.V., Yearsley J., Abplett 
C.A., Kenis P.J.A., Design Considerations for Elastomeric Normally Closed Microfluidic Valves. Sensors & 
Actuators B, 2011, 160(1), 1216.  
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out of elastomeric materials, such as polydimethylsiloxane (PDMS), a commonly used material 
in microfluidics.  Valves made out of elastomeric materials are typically easier to fabricate and 
actuate at lower pressures.  Elastomeric NC valves have been used previously in different 
microfluidic applications, including cell sorting (12), on-chip electrophoresis (1), combinatorial 
protein-antibody interaction screening (5), virus detection (6) and on-chip chemical synthesis (13, 
14).  Some of these NC valves have been characterized for pumping of fluids for a range of flow 
rates (0-400 nL/s) and operating pressures (0-30 kPa) (15).  None of these studies, however, have 
specifically focused on design rules to optimize the performance of NC valves, in particular with 
respect to minimizing their actuation pressures and improving their reliability. 
 
2.2 Design of Normally Closed Valve 
2.2.1 Microvalve Design for Optimization 
To actuate (i.e., open) a NC valve, the membrane that is connected with the valve stop 
needs to get deflected upwards under the influence of an applied pressure that is lower than 
ambient (Fig. 2.1).  The key factors that determine the actuation pressure are (a) the mechanical 
properties of the membrane, and (b) the adhesion forces between the valve stop and the surface it 
rests on.  In turn, these factors depend on a variety of parameters, including the thickness of the 
membrane, the bulk and surface properties of materials used, and the dimensions of the control 
and fluid channels. 
Fig. 2.1(a) shows cross-sectional views of a NC valve in the closed and open state.  The 
microvalve consists of a control layer with a channel height (hc) and a fluid layer with a channel 
height (hf).  The main operational part of the valve consists of a membrane with a thickness (t), 
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and a valve stop with a width of 50 μm to block the flow.  Fig. 2.1(b) shows a perspective view 
of the NC valve. 
Fig. 2.1(c) shows optical micrographs of a NC valve in the closed and open state.  In this 
figure, the circular or oval-shaped contact area (i) indicates the region of the fluid channel that is 
lifted off the glass substrate, while (ii) indicates the region of the valve membrane that touches 
the roof of the control channel.  To study the effect of asymmetry on valve performance, I varied 
two parameters: (1) the shape of the valve stop: straight, diagonal, or v-shaped, and (2) the 
position of the valve stop within the control chamber, as quantified by the ratio L1:L2 ranging 
from 1:1 to 1:5 (Fig. 2.1(c)).  The rationale behind introducing asymmetry is the creation of a 
weak point along the contact line of the adhering substrates, so these surfaces can detach from 
each other more easily upon application of a smaller pressure difference.  The width of the fluid 
channel (w) was also varied from 50 to 350 μm, which is expected to influence the adhesive 
contact area between the valve stop and the glass substrate, and consequently the actuation 
pressures.  To study the effect of valve membrane thickness on the actuation pressures, I varied 
the thickness from 16 to 60 µm, and tested for actuation pressures with and without substrate.  
The rationale behind testing of the valves with and without substrate (glass) is to figure out 
whether adhesion is dominant compared to mechanical properties of the valves or vice versa.  In 
addition, this valve design can be easily fabricated using standard multi-layer soft lithography. 
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Fig 2.1.  (a) Cross-sectional and (b) perspective schematic views of a normally closed straight microvalve 
in closed and open state.  (c) Optical micrographs (top view) of a valve in the closed and open state.  (i) 
indicates the region of the fluid channel that is lifted off the glass substrate, while (ii) indicates the region 
of the valve that touches the roof of the control channel. 
2.2.2 Alternative Design Layouts Tested 
 I tested alternative NC valve design layouts first before I converged on a final layout as 
our standard.  Initially, I tested different sized valves with varying fluid channel widths for 
measuring actuation pressures on the same control line as our vacuum source.  However, I 
concluded that the design was not an accurate representation of the actuation pressures for a 
single valve with specific dimensions due to pressure losses along the control line.  The valves 
which were located away from the vacuum source did not always actuate.  Fig. 2.2 shows the 
layout set up with multiple valves controlled by a single line as discussed above. 
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Fig. 2.2.  Alternative testing design for an array of NC microvalves.  All the valves controlled by a single 
control line.  
To circumvent the issue of pressure losses, I decided to test the microvalves individually with 
each valve having its own control line.  Hence, all the pressure values obtained for the studies 
reported in this thesis are for an individual valve only, unless the objective is to test a network of 
dense valves, in which case the valves will be connected by a single control line.  In addition, our 
original experimental set up only consisted of a 3-way pressure valve to control the pressure, and 
a pressure gauge which measured all the values for actuation pressures.  This method was 
considered crude. Hence, I decided to use a more sophisticated method to measure the actuation 
pressures.  Specifically, I utilized a pressure controller as described later in our experimental set 
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up.  This controller helped us measure the actuation pressures with much greater accuracy 
(1/100th of decimal) than our previous set up in addition to giving reliable results.  The table 
below shows quantitative results obtained with alternative layout as shown in Fig. 2.2.  
Valve size 
(µm) 
Pressure recorded 
(torr) 
325 Fail 
300 Fail 
275 Fail 
250 Fail 
225 428 
200 481 
175 533 
150 520 
125 471 
100 444 
75 433 
50 266 
Table 1.  Quantitative results obtained with an alternative set up as shown in Fig. 2.2. 
As indicated in in Table 1, some valves located furthest from the vacuum source  failed to open.  
The table shown above is only for one experiment, but similar results were obtained from 
multiple experiments with different pressure values due to the crude method used for quantifying 
actuation pressures.   
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2.3 Fabrication of Normally Closed Valve 
2.3.1 Soft Lithography 
I fabricated microfluidic devices with NC valves using standard procedures for PDMS-
based multi-layer soft lithography (16).  The fabricated two-layer devices consisted of (a) a 
control layer composed of microchannels that act as pneumatic lines for applying negative 
pressure and (b) a fluid layer composed of microchannels.  RTV 615 poly (dimethyl siloxane) 
(PDMS) was obtained from General Electric Company (Waterford, NY).  Negative photoresists, 
SU-8 250 and SU-8 25, were obtained from MicroChem Corporation (Newton, MA).  
(Tridecafluoro-1,1,2,2-tetrahydrooctyl)trichlorosilane was obtained from Gelest, Inc. 
(Morrisville, PA).  The thickness of the photoresist and PDMS layers were measured using 
profilometry (Dektak 3030).  Negative patterns of the features of the fluid layer and the control 
layer were patterned on silicon using 20-25 μm thick negative photoresist.  Then, a silane 
monolayer was evaporated onto the silicon masters to prevent the covalent adhesion of PDMS to 
the silicon substrates.  Next, a thin layer of 15:1 PDMS (weight ratio of polymer to cross-linker) 
was spun on the fluid layer master, 5:1 PDMS was poured on to the control layer master to a 
thickness of 2 mm, and the two layers were partially cured at 65 °C for approximately 30 
minutes.  The thickness of the valve membrane in the fluid layer was controlled by the spin 
speed ranging from 1000 to 2000 rpm, yielding 20-60 µm layer thicknesses.  After partial curing, 
the control layer mold was removed from the master, holes were punched for the inlets and 
outlets of the control layer using a 20 gauge needle (B-D Precision Slide), and the control layer 
mold was aligned manually with the fluid layer under an optical microscope (Leica MZ6).  The 
aligned layers were further cured at 65 °C for approximately 12 hours to yield the final 
assembled device.  The device was then peeled off the fluid layer master, and holes were 
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punched into the fluid layer using a 20 gauge needle.  For experiments studying the reversibly 
sealed nature of the PDMS devices, the device was placed onto a clean glass substrate by simply 
bringing the PDMS assembled mold and the glass into contact.  I chose a glass substrate, as glass 
is the most commonly used substrate in microfluidic devices when the channels are fabricated 
out of PDMS (17, 18).  Since the objective of the research presented here was to study the 
influence of valve geometry on actuation pressures, I did not modify the material properties of 
PDMS. 
 
Fig 2.3.  Pneumatic microvalves made with soft-lithographic techniques (19).  Shown schematically are (a) 
the fabrication procedure for the valve, (b) valve cross-sections, and (c) the actuation of the valve with 
pneumatic pressure. 
In some of the experiments, the PDMS device was irreversibly bonded to glass.  In this 
case, the surface of the assembled device that had the microfluidic features and the glass 
substrate were treated with atmospheric plasma consisting of oxygen and helium (1:75 
volumetric ratio) using a plasma pen (Surfx technologies, AtomfloTM plasma) at 80 W for 2 to 4 
seconds.  After the plasma treatment, all NC valves were actuated so that the valve stops do not 
touch the glass substrate during bonding, and the PDMS device and the glass were brought into 
(a) (b)
(c)
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contact.  The valves were left actuated for approximately 6-8 hours, after which the PDMS 
device was irreversibly bonded to glass only in the channel areas. 
Negative pressure was applied to the NC valves using a pump (Gast DOA-P704-AA 
Vacuum Pump 1/8 HP 115 VAC), and the actuation pressures of the microvalves were measured 
using a pressure controller (Cole Parmer, model 68027-78); the schematic illustration of the set-
up is shown in fig. 2.4.  The valve actuation was performed under an optical microscope (Leica 
M205) to confirm opening of the valve.  Note that the valve is open and will allow fluid flow, 
when the valve stop is lifted off from the substrate.  However, this partial opening of the valve 
cannot be ascertained by visualizing the device from the top (Fig. 2.1c).  Hence, I define the 
open state of the valve based on formation of contact lines.  Two sets of contact lines appear 
upon actuation, one due to gradual delamination of the valve stop and side walls of the fluid 
channel, and one due to adhesion of the valve membrane to the roof of the control channel.  
Specifically, the valve is defined as ‘completely’ open when at least one of the two contact lines 
(typically circular or oval in shape) links the two opposite edges of the valve stop (Fig. 2.1c).  I 
thus define ‘actuation pressure’ as the pressure required to completely open the valve, based on 
our definition of ‘completely’ open valve.  After testing 8 different devices, I observed that the 
actuation pressures for all the valves were in the range of 1 – 6 psi.  The standard deviation for 
actuation pressures for valves with identical geometries (same dimensions) on different devices 
was ±0.15 psi, which I represent as 0.3 psi error bars in Fig. 2.3.  This implies that the device-to-
device variability resulted in a 0.3 psi variation in actuation pressures.  Each valve on the same 
device was tested in triplicate, and I observed that the actuation pressures for that same valve 
were within 0.01 psi.  Note that all the valves were tested without flow in the fluid channels, and 
the actuation pressures refer to static values. 
17 
 
2.3.2 Experimental Set Up 
Fig. 2.4 shows a schematic of the experimental setup I used to actuate the NC valves, and to 
determine the actuation pressures needed to open a given valve.  The pressure controller allowed 
us to set the actuation pressure, as well as measure the actuation pressure for each valve. 
 
 
Fig. 2.4.  Schematic illustration of the setup for actuating NC valves.  For clarity, only one valve is shown.  
 
2.4 Conclusions 
NC valves are an alternative to the more common NO valves especially in applications 
that require long term continuous closed state of the valves.  NC valves not only address the 
issue of restricted portability, but also retain the ease of fabrication, and integration into 
microfluidic devices.  These valves can typically be actuated at lower pressures than NO valves.  
Even though, the valves have been used in various microfluidic applications, and characterized 
for pumping fluids for a range of flow rates and operating pressures, I have characterized these 
valves for the first time with respect to improving actuation reliability and minimizing actuation 
pressures.  Furthermore, the fact that NC valves require actuation only during filling of a 
microfluidic device after which all ancillaries can be disconnected, benefits those applications 
that involve subsequent on-chip analysis of chemical or biological processes in confined spaces. 
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Chapter 3 
Optimization of Actuation Parameters for Normally Closed Valves1 
3.1 Introduction 
Formulation of design rules for normally closed microvalves is important because 
actuation of microvalves involves complex interplay between (i) mechanical deformation of the 
membrane and (ii) adhesion forces between hard and soft materials, which cannot be quantified 
easily due to the hysteresis that appears when polymeric substrates contact a stiffer surface.  In 
addition, design rules are needed for devices with dense networks of channels because pressure 
losses across the device may cause failure of the valves that are furthest away from the actuation 
pressure source.  Hence, design rules are needed that will aid in minimizing actuation pressures 
for these cases.  Furthermore, the design rules will enable fabrication of valves with dimensions 
that can be easily achieved with standard soft lithography. 
Previous studies for designing microvalves usually vary relevant parameters such as size, 
thickness, and shapes of the valves to study actuation pressures or other important parameters 
such as potentials necessary for a valve actuation(1-3).  Design rules for the valves were 
established by optimizing various relevant parameters for the normally closed valves.  The 
parameters for these pneumatic normally closed normally closed valves were chosen such that 
each parameter affects the actuation pressures with the goal of minimizing actuation pressures.   
                                                            
1 Part of this work has been published:  Mohan R., Schudel B.R., Desai A.V., Yearsley J., Abplett C.A., Kenis P.J.A., 
Design Considerations for Elastomeric Normally Closed Microfluidic Valves. Sensors & Actuators B, 2011, 160(1), 
1216.  
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3.2 Optimization of Normally Closed Valve Parameters 
3.2.1 Membrane Thickness 
Membrane thickness influences membrane stiffness, which in turn influences membrane 
deformation and consequently the actuation pressures.  I studied thickness dependence for 
straight valves only, and the fluid channel width was maintained constant at 175 μm.  I observed 
that the actuation pressures change only marginally (2.4 – 2.6 psi) for valves with different 
membrane thicknesses, ranging from 16 to 60 μm.  Apparently, other parameters also determine 
the actuation pressure, in particular adhesion forces (see below).  I also observed that the 
actuation pressures decrease with decrease of the membrane thickness without a glass substrate 
(Fig. 3.1).  This trend is expected because the pressure required to deflect membranes increases 
with increased thickness (4).  Based on the above observations, I conclude that the actuation 
pressure is primarily governed by the adhesion between the contacting surfaces and not by the 
membrane stiffness.  Since the actuation pressures are not significantly influenced by membrane 
thicknesses (for the range of values tested here), thicker membranes are preferable, since thinner 
membranes are susceptible to collapse during fabrication (5) and are usually unreliable during 
operation (inconsistent actuation pressures).  Hence, for all the experiments, I used a membrane 
thickness of an intermediate value, approximately 36 μm, which yielded reliable valve operation, 
i.e., variations in actuation pressures for the same valve were within 0.01 psi for different trials.    
21 
 
 
Fig. 3.1.  Effect of thickness of the membrane (t) on actuation pressures, when tested without any 
substrate.  For comparison, I also have included pressure values with a glass substrate.  Thicknesses of 
16, 36, and 60 μm were tested.  Each data point represents the average from experiments on 8 identical 
valves.  Each valve was tested three times.  
3.2.2 Fluid Channel Width 
Since adhesion forces were postulated to affect the actuation pressures, and the area of 
adhesion scales with the fluid channel with, I varied fluid channels widths.  For all three valve 
shapes, I observed that the actuation pressures decreased with increasing fluid channel width (Fig. 
3.2).  However, the actuation pressures measured for devices without any substrate do not show 
dependence on width.  Hence, the width-dependence of the actuation pressures is primarily due 
to the adhesion between the valve and the glass substrate.  To explain this width-dependence, I 
derived scaling laws for the actuation pressure based on the peeling of soft rectangular strips 
from hard substrates (details of this derivation are provided in the Appendix, Section 2).  For 
straight valves, the actuation pressure (ΔP) scales as 
wL
P 11
0
 ,  (1) 
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Where w is width of the fluid channel, 2L0 = L1 + L2 (Fig. 2.1(c) for definition of L1 and L2).  
Note that L0 was maintained constant for all the experiments.  The width-dependence of 
actuation pressures can also be explained by considering the area of valve contact with glass, 
which increases with decreasing width.  In this case, it can be shown that the actuation pressure 
scales as (details of derivation in supplementary information, Section 2) 
cL
wP  1 ,  (2) 
where Lc is the width of the square chamber in the control layer (Fig 2.1(c)).  I speculate that 
Eq. (1) (based on peeling) captures the actuation phenomena more accurately compared to Eq. (2) 
(based on area of contact). In other words, peeling is the more dominant mode of actuation, and 
hence, I observe a non-linear decrease in actuation pressures with decreasing channel width.  In 
case of V-shaped and diagonal valves, the corner feature determines the actuation pressure, and 
hence, Eq. (1) may not be applicable, since the equation is derived on the basis of peeling of a 
rectangular strip.  However, the width-dependence of actuation pressures for these valves can 
still be explained using Eq. (2). 
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Fig. 3.2.  Actuation pressure for different microvalve shapes (straight, V-shaped, and diagonal) as a 
function of the width of the fluid channel.  Each data point represents the average value from three 
experiments using the same valve.  The errors represented in the plot originate from device-to-device 
variability, which were a maximum of 0.3 psi for identical valves on 8 different devices.  
3.2.3 Valve Stop Shape 
Symmetry may reduce actuation pressures because it introduces a weak point in the 
adhesion between the valve stop and the substrate.  One of the ways I introduced asymmetry was 
by modifying the shape of the valve stop.  Fig. 3.2 shows the experimentally determined 
actuation pressures as a function of fluid channel width for three different shapes of the valve 
stop: straight, diagonal and V-shaped.  I observed that the actuation pressures were lower for V-
shaped valves compared to those for straight valves (Fig. 3.2).  To explain this shape dependence, 
I describe the actuation of the valve as peeling of a soft adhesive strip (PDMS valve) off a hard 
substrate (glass).  The peeling of the strip (e.g., a scotch tape on a hard substrate) is typically 
easier from a corner as opposed to peeling from the edge, and hence, the actuation pressures are 
expected to be lower for V-shaped valves with a corner feature than for straight valves.  The 
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lower actuation pressures required for V-shaped valves can be explained semi-quantitatively by 
considering the relation between the force required to peel (peeling force) and the width of the 
feature being peeled.  Within a first order of approximation, the peeling force is proportional to 
the width (6, 7).  In case of a V-shaped valve, the corner feature results in a very small local 
width, on the order of the radius of curvature of the corner (~10 μm), while for a straight valve, 
the peeling width is the whole channel width (~100 μm).  Due to the differences in peeling 
widths, the actuation pressures for V-shaped valves are lower than those for straight ones.   
Interestingly, I also observed that the actuation pressures for diagonal valves are higher 
than those for straight ones, in spite of the presence of a corner feature.  This observation mainly 
results from the fact that for the diagonal valves the corner feature is located away from the 
central axis.  The opening of the valve is initiated along the central axis (Fig. 2.1 (c)), since the 
valve is least constrained to deflect upwards at the center of the fluid channel.  This deflection 
profile for the valve can be understood in terms of deflection of a fixed-fixed beam (8) (cross-
section BB/ , Fig. 2.1(a)).  Since valve opening occurs along the central axis of the channel, 
actuation pressures will be lower only if the peeling forces are small at the center of the valve.  In 
case of diagonal valves, the peeling forces are minimized at the valve edges, and not at the center, 
thus leading to higher actuation pressures.  In contrast, the V-shaped valves have the corner 
feature along the central axis, and hence actuate at lower pressures.  Based on the above 
discussion, I conclude that the peeling forces should be minimized in the region where the valve 
opening is initiated to result in lower actuation pressures.  A more rigorous explanation for the 
shape-dependence of actuation pressure based on stress concentration and crack initiation can be 
found in the appendix. 
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3.2.4 Valve Stop Placement 
Another way I lowered symmetry in the valve geometry was by varying the position of 
the valve stop (See Fig. 3.1) within the control line chamber, which I quantified using the ratio 
L1:L2 (Fig. 2.1(c)).  In the case of straight valves, I observed that the actuation pressures were 
similar for L1:L2 ratios of 1:1 and 2:1, and decreased for 5:1 ratio (Fig. 3.3).  I attribute this 
decrease in actuation pressure to the fact that in the latter case one of the membrane lengths is 
significantly larger than the other.  A larger membrane length (L1 here) will lead to lower 
stiffness of the corresponding membrane (upper membrane in Fig. 2.1(c)).  As a result, the 
membrane deflects at a much lower applied pressure and the membrane touches the ceiling of the 
control channel, as evident from the contact line at the center of the larger membrane in  
(Fig. A.6).  Then, upon the application of additional pressure the outer contact line rapidly 
propagates, since additional deformation of the membrane, and hence extension of the inner 
contact line is hindered by contact of the membrane with the ceiling (Fig. A.6).  I speculate that 
this rapid propagation of the outer contact line linking the two opposite edges of the valve stop 
leads to lower actuation pressures for straight valves with L1:L2 ratios of 5:1. 
Interestingly, in case of V-shaped valves, I observed a reverse trend, where the actuation 
pressures increased when the L1: L2 ratio was varied as 1:1, 2:1 and 5:1 (Fig. 3.3).  I speculate 
that as the L1: L2 ratio increases in V-shaped valves the axial distance of the shorter side (L2) is 
much shorter than in the case of straight valves, due to the presence of the corner feature in V-
shaped valves.  As a result, the pressure required to deflect the membrane along the central axis 
increases significantly due to the shorter length.  Hence, the increase in length of the larger side 
(L1) is more than offset by the reduction in length of the shorter side.  This effect is more 
pronounced in V-shaped valves compared to straight valves, since the opening of V-shaped 
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valves is predominantly along the central axis due to the sharp corner feature.  Consequently, I 
observed an increase in actuation pressures with increasing asymmetry in V-shaped valves, due 
to drastic reduction in the membrane dimension along the central axis.  A more rigorous 
explanation for the asymmetry-dependence of actuation pressure for V-shaped valves based on 
stress concentration and crack initiation can be found in the appendix. 
 
Fig. 3.3. Effect of asymmetry on actuation pressures for straight and V-shaped valves.  Asymmetry ratios 
tested were 1:1, 2:1, and 5:1.  
3.2.5 Effect of Control Channel Height on Hysteresis in Valve Actuation Pressures 
Hysteresis becomes important during dynamic, repeated actuation of the valve, since the 
different pressures required to open and close the valve may lead to temporal delays in operation.  
Hence, minimizing hysteresis is important for precise control of microfluidic metering and flow 
control (9).  In NC valves, hysteresis primarily results from the valve membrane adhering to the 
roof of the control channel in the open state, which is illustrated by formation of a circular or 
oval shaped contact line in Fig. 3.4.  The hysteresis of adhesion and detachment of the membrane 
from the roof, typical during adhesive contact between two elastic surfaces, causes hysteresis in 
the actuation pressures of these valves.   
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Fig. 3.4.  Semi-quantitative hysteresis plot of actuation pressures for NC valves.  Two different heights for 
the control channel were tested, 20 and 50 μm.  The fluid channel width in all the optical micrographs was 
175 μm.  The valve is considered open when the oval contact line touches the roof of the control channel 
and the shorter axis of the oval is approximately the size of the fluid channel width (see Fig. 2.1(c) ) The 
colors of the optical micrographs have been artificially modified to differentiate the two types of valves.  
Lines connecting the data points are added to guide the eye. 
In Fig. 3.4, I plot the degree by which the valve opens as a function of actuation pressures, 
where I define the valve as open when the oval contact line touches the roof of the control 
channel and the shorter axis of the oval is approximately the size of the fluid channel width; 
Fig. 2.1(c) shows an open valve.  To estimate the fraction of valve opening, the length of the 
shorter axis of the oval contact line is compared to that of an open valve.  The actuation 
pressures were higher for the taller control channels, since the valve had to deflect a larger 
distance upward to touch the roof of the control channel.  However, I observed lower hysteresis 
for the taller control channel, i.e. the ratio of the area enclosed within the curve to the actuation 
pressure is lower for the taller control channel.  I attribute the lower hysteresis to the fact that a 
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taller control channel allows for more relief of the membrane deformation when the pressure is 
decreased, since the membrane is stretched more in a taller control channel.  This additional 
relief results in easier detachment of the valve membrane from the roof, which leads to lower 
influence of the adhesion forces between the membrane and the roof when pressure is decreased.  
Note that the higher actuation pressure for the device with a taller control channel is mainly due 
to our definition of an open valve.  In reality, devices with taller control channels are preferable 
since the valve can deflect over larger distances, and hence allow more fluid to pass through the 
fluid channel in the open state. 
 
3.3 Operational Considerations 
3.3.1 Valve Performance in Dense Network 
In microfluidic devices with dense networks, the actuation pressures increase across a 
network of serially connected valves, due to leakage or pressure losses associated with increasing 
channel length.  As a model for dense microfluidic network, I tested the performance of NC 
valves by actuating 44 identical valves in series (a schematic illustration and an actual image of 
the device is shown 6.7) and compared the valve performance to those in a device with only 3 
valves in series.  Additionally, to demonstrate the advantage of valves operating at lower 
actuation pressures in dense networks, I compared valve performance in devices with V-shaped 
(lower actuation pressures) and straight valves.  The fluid channel width was 175 μm and the 
L1:L2 ratio was 1:1.  In devices with straight valves, 9 out of the 44 valves did not actuate 
(maximum pressure applied was 12 psi), however, in devices with V-shaped valves, all of the 44 
valves actuated in the range of 2 to 5 psi.  As expected, all the 3 valves in the simpler 
microfluidic device actuated for both valve shapes.  The above experiments demonstrate that 
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optimization of valve geometry to reduce actuation pressures and to ensure reliable actuation is 
crucial for the design of integrated microfluidic networks that contain NC valves. 
3.3.2 Valve Actuation for Reversibly and Irreversibly Bonded Devices 
Leakage due to weak device-to-substrate bonding may present issues in microfluidics, 
especially during fluid manipulation.  In case of NC valves, the leakage issue becomes even 
more important due to the requirement of selective bonding, where strong bonding is needed for 
the channels, while the valves remain non-bonded.  Although, Yang et al. (10) and Irimia et al. 
(11) were able to achieve selective irreversible bonding, their technique required additional 
fabrication steps, such as patterning of a metallic or polymeric layer at the valve stop.  Here, I 
developed a simpler alternative to selectively bond microfluidic devices with NC valves.  
Oxygen plasma treatment of glass and PDMS as an irreversible bonding technique has been 
characterized in previous work and is known to lead to strong irreversible bonding (5).  I utilized 
this technique to irreversibly bond the PDMS device to glass substrate.  To prevent the valves 
from permanently sealing to glass, I exposed the PDMS and glass surfaces to oxygen plasma and 
then actuated the valves before bringing the PDMS and glass substrate into contact, so that the 
valves do not contact the glass.  I left the valves actuated for 6 – 8 hours, which was sufficiently 
long for the PDMS surface to lose its hydrophobicity and consequently, the tendency to 
irreversibly bond to glass (12).  As a result, the device is irreversibly bonded to the glass 
substrate, except in the areas where the valve stop contacts the glass. 
Since the adhesion forces between glass and PDMS are known to increase with time (13) 
and hence expected to influence the valve operation, I measured the actuation pressures of 
reversibly and irreversibly bonded devices with glass substrate over a period of 4 weeks.  For 
these experiments, I used V-shaped valves, L1: L2 ratio of 1:1, and a channel width of 175 μm.  In 
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case of reversibly bonded devices, I observed that the actuation pressures increased with time (4 
weeks), if the PDMS device and the glass substrate are maintained in contact, while in case of 
irreversibly bonded devices, the actuation pressures remained nearly constant over time; a 
qualitative plot indicating the effect of device-substrate contact time on actuation pressure is 
shown in Fig. 3.5.  The increase in actuation pressures for reversibly bonded devices can be 
attributed to time-dependent plastic deformation (creep) of PDMS over micro and nanoscopic 
features on the glass substrate.  This creep-assisted deformation was observed in one study, 
where PDMS was shown to plastically deform and encapsulates nanoparticles gradually over 
time (14).  This encapsulation over time will lead to an increase in contact area of the PDMS 
valve with the glass substrate and hence stronger adhesion, thus resulting in increasing actuation 
pressures with time.  In case of irreversibly bonded devices, however, the actuation pressures 
remained almost constant over time (Fig. 3.5).  This behavior is due to the fact that the plasma 
treatment used for irreversible bonding hardens the PDMS surface by formation of a thin oxide 
layer (~100 nm, small compared to the thickness of the valve membrane) (12), which retards the 
ability of PDMS to plastically deform.  
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Fig. 3.5.  Qualitative plot showing the effect of device-substrate contact time on actuation pressures for 
reversibly and irreversibly bonded devices.  The dashed vertical line indicates that reversibly bonded 
device could not be actuated. 
I also observed that the actuation pressures at the beginning for irreversibly bonded 
devices are approximately 1 psi higher compared to those for reversibly bonded device (Fig. 3.5).  
The plasma exposure during irreversible bonding decreases the surface roughness of both the 
PDMS and the glass, which in turn increases the contact area.  The increased contact area leads 
to stronger adhesion, and consequently, higher actuation pressures.  However, in the case of 
reversibly bonded devices, after the PDMS device was peeled off and brought into contact again 
with the glass substrate, the actuation pressures returned to its original values.  I speculate that 
the peeling of the PDMS breaks the adhesive bonds with the glass surface and new bonds are 
formed when the PDMS is brought into contact again.   
 
3.4 Conclusions 
Based on the above experimental results and discussion, I formulate the following set of 
design rules to integrate NC valves into microfluidic devices:  
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1. Valve shape: V-shaped valves are better than straight valves or diagonal valves in terms of 
actuation pressures and reliability, because they not only actuate at lower pressures than 
straight for the same fluid channel width, but V-shaped valves also actuate more consistently 
and their actuation pressure vary less from device to device. 
2. Fluid channel width:  Actuation pressures do not significantly change (only 2 – 3 psi) for a 
wide range of fluid channel widths (Fig. 3.3), 50 - 400 μm.  Hence, the NC valves reported in 
this thesis can be used in microfluidic devices with different channel widths. 
3. Membrane thickness:  For membrane thicknesses in the range of 15 – 60 μm, the actuation 
pressures did not vary significantly (only 1 – 3 psi).  However, thicker membranes are 
preferable, since valves with thicker membranes actuate more reliably, and valves with 
thinner membranes are more challenging to fabricate. 
4. Position of valve stop:  For straight valves, inducing asymmetry by changing the position of 
the valve stop reduces actuation pressures, but fabrication limitations might constrain the 
extent of asymmetry.  For instance, in our devices, I could not lower the symmetry in the 
position of the valve stop beyond a L1:L2 ratio of 5:1.  For V-shaped valves, moving the valve 
stop does not have a beneficial effect.  
5. Hysteresis in valve actuation:  For taller control channels (50 μm), the hysteresis of valve 
actuation was lower compared to that for shallower channels (25 μm), and hence, taller 
control channels are preferable, especially for dynamic actuation.  Moreover, taller channels 
allow for more fluid displacement.  
6. Bonding: Selective irreversible bonding will minimize liquid leakage in devices.  However, 
in applications where the PDMS device needs to be peeled off (e.g., when cleaning of the 
channels is not possible in an assembled device) or the glass substrate cannot be exposed to 
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plasma treatment (e.g., glass surface has been functionalized with oxygen-sensitive chemical 
groups), then reversible bonding is preferable. 
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Chapter 4 
A Microfluidic Platform for Antibiotic Susceptibility Screening 
4.1 Introduction 
 Microfluidics is a rapidly emerging technology for biological studies, which enables 
time-resolved investigation of cellular phenomena in precisely controlled environmental 
conditions and with single cell resolution (1-10).  Additionally, microfluidics facilitates high 
throughput studies by simultaneous implementation of diverse experimental conditions on-chip, 
while at the same time utilizing minimal sample and reagent volumes (1-3).  The aforementioned 
advantages, coupled with low production costs and ease of fabrication of microfluidic chips by 
soft lithography,  have extended their application to various processes such as protein 
crystallization, cell sorting, pharmaceutical screening, biological & chemical sensing, and 
genome sequencing (11-19). 
 Fluorescent proteins are extensively used as reporters of gene expression and metabolic 
activity in live cells (20).  Fluorescent protein technology coupled with flow cytometry 
(Fluorescence Activated Cell Sorting, FACS)  and Time Lapse Fluorescence Microscopy (TLFM) 
enable cellular analysis with single cell resolution(21-25).  However, FACS is limited in time 
resolution and entails laborious sample preparation and high costs (26).  Microfluidic techniques 
coupled with TLFM represent a transformative technology for characterizing cellular dynamics 
with exquisite spatiotemporal resolution, which is a key advantage offered by microfluidics in 
biological applications (22, 27-33). 
 Previously reported microfluidic platforms are comprised of arrays of chambers 
harboring cells & chemical stimuli, and incorporate valves for fluidic routing.  These platforms 
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have enabled investigation of cellular response to diverse stimulants in a high throughput and 
combinatorial fashion (34-36).  Fig. 4.1(a) shows an example of a micro-chemostat for long term 
cell analysis (37).  However, use of this device is laborious to assemble and has limited 
portability due to the use of normally open (NO) valves for fluidic manipulations.  The need for 
continuous actuation of NO pneumatic valves in these chips necessitates ancillaries such as 
syringe pumps, flow control valves, and multiple pneumatic connectors and tubing, thereby 
limiting the portability of the chips.  Additionally, while some groups have trapped single cells 
or cell populations for long-term analysis (38-40), others have concentrated on trapping cells 
with simultaneous manipulation of the cellular microenvironment (41, 42).  As an example, Fig. 
4.1(b) depicts prior work  demonstrating microfluidic platform for high throughput screening of 
the effects of various antibiotics on  E. coli cell growth  (43).  However, the microfluidic device 
requires continuous supply of nutrient medium to sustain cell viability thereby limiting 
portability.  Furthermore, the absence of control valves restricts controlled fluidic mixing, and 
the device relies chiefly on diffusion to transport nutrients and antibiotics to cells.  In a landmark 
study by Balaban  et al.,  microfluidic  devices with sub-micron sized grooves (Fig. 4.2(a)) were 
employed to constrain E. coli cells in linearly expanding chains to investigate bacterial tolerance 
to long term antibiotic stresses (44, 45).  Fig. 4.2(b) shows yet another example of a simple 
microfluidic device, which was used for long-term single cell cultivation and tracking.  Both 
these devices have limited combinatorial capabilities, require continuous flow of growth media, 
and employ diffusion across membranes or between laminar streams to deliver nutrients.  Hence, 
a key challenge is to develop microfluidic platforms that integrate multiplexing capabilities with 
improved portability while at the same time enabling elaborate spatiotemporal resolution 
associated with microscale analysis. 
36 
 
 
Fig. 4.1.  (a) Device for functional circuit used for long-term bacterial colony monitoring and antibiotic 
testing in a high-throughput manner (43). Image reprinted from Science, 309, F.K. Balagadde, L.  You, 
C.L. Hansen, F.H. Arnold, S.R. Quake, Long-Term Monitoring of Bacteria Undergoing Programmed 
Population Control in a Microchemostat,  137-140, 2005 with permission from The American Association 
for the Advancement of Science. (b) Optical micrograph showing six microchemostats those operate in 
parallel on a single chip.  Various inputs have been loaded with food dyes to visualize channels and sub-
elements (37). Image reprinted from Biosensors and Bioelectronics, 26, P. Sung, Y. Liu, J. Sha, Z. Zhang, 
Q. Tu, P. Chen, J. Wang.  High-throughput microfluidic system for long-term bacterial colony monitoring 
and antibiotic testing in zero-flow environments, 1993-1999, 2011 with permission from Elsevier. 
 
 
Fig. 4.2.  (a) Device to trap cells at the interface between transparent membrane and a thin layer of 
PDMS patterned with narrow grooves (44). Image reprinted from Science, 305, N.Q. Balaban, J. Merrin, 
R. Chait, L. Kowalik, S. Leibler, Bacterial Persistence as a Phenotype Switch, 1622-1625, 2004 with 
permission from The American Association for the Advancement of Science.  (b) Device for long term 
single cell tracking (46). Image reprinted from Lab Chip, 10, L. Wong, S.  Atsumi, W.C. Huang, T.Y. Wu, 
M.L. Lam, P. Tang, J. Yang, J. C. Liao, C.M. Ho, An agar gel membrane-PDMS hybrid microfluidic device 
for long term single cell dynamic study, 2710-2719, 2010 with permission from The Royal Society of 
Chemistry.  
An approach to address the above challenge is to utilize microfluidic array chips incorporating NC valves, 
which greatly simplifies chip operation and handling.  In previous work, the Kenis group developed a 
multiplexed microfluidic chip (Fig. 4.3) utilizing NC valves presenting several key advantages (47).  (i) 
They do not require continuous actuation since they are closed in the rest position.  (ii)  The need to 
(a) 
(b)
(a) (b)
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irreversibly seal the device to the bottom substrate is eliminated.  (iii) Since PDMS is gas permeable, the 
need for reagent feed lines when fluids are pipetted on fluid inlets are eliminated, which drastically 
reduces dead volume.  (iv) NC valve chip is highly portable since all the lines can be removed after filling.  
(v) NC valve chips can have high degree of complexity because valve area overlaps with compartment 
area instead of being located in-between compartments (47).  In order to investigate the advantages of 
implementing NC microvalves in microfluidic platforms for biological studies, I characterized and 
optimized these valves with respect to their integration in high-density array chips.  Additionally, as 
discussed in Chapters 2 and 3, I formulated design rules to assemble a microfluidic platform that 
incorporates these valves to route fluids within an array of ~2 nL volume chambers.  These new chip 
configurations based on NC valves minimize solvent loss, while drastically easing portability between 
loading and analytical stations.  These features enable quantitative and time resolved biological studies 
for several hours (>15 hours) to be performed on-chip in a high throughput and combinatorial fashion.  
These NC valves also facilitate periodic supply of nutrient media, as well as the exposure of the cells to 
different chemical stimuli loaded in contiguous compartments.  The latter two features set this work apart 
from alternative approaches that typically require continuous flow (46). 
 
Fig. 4.3.  Multiplexed microfluidic devices utilizing normally closed valves for biological applications such 
as (a) protein binding and (b) virus detection(47, 48). Images reprinted from Lab Chip, 9, B.R. Schudel, 
C.J.Choi, B.T. Cunningham, P.J.A. Kenis, Microfluidic Chip for Combinatorial Mixing and Screening of 
Assays, 2710-2719, 2010  and Lab Chip, 11, B.R. Schudel, M. Tanyeri, A. Mukherjee, C.M. Schroeder, 
P.J.A. Kenis, Multiplexed Detection of Nucleic Acids in a Combinatorial Screening Chip, 1916-1923, 2009, 
respectively, with permission from The Royal Society of Chemistry.  
(a) (b)
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I used a modified multiplexed microfluidic platform from Fig. 4.3 for biological screening 
applications, specifically to study the effect of diverse antibiotics on E. coli cells. The overall 
goal behind antibiotic susceptibility studies using these multiplexed microfluidic chips is to 
develop diagnostic platforms for screening clinical samples for antibiotic resistance.  Antibiotic 
overuse and incorrect use over the past seven decades has resulted in the widespread emergence 
of antibiotic resistance amongst clinical pathogens, which poses a critical global health issue.  
The rapid emergence and spread of Multi-Antibiotic Resistant (MAR) pathogens (for example – 
Methicillin Resistant Staphylococcus aureus (MRSA), Mycobacterium tuberculosis, 
Vancomycin Resistant Enterococcus) calls for the development of alternate antibacterial 
therapeutic strategies (49).  Currently employed therapeutic strategies to combat MAR pathogens 
involve the administration of multiple antibiotics in combination.  A key requirement for 
establishing a combinatorial treatment regimen concerns identifying the specific antibiotics the 
MAR strain is resistant to.  Existing methods to identify and quantify antibiotic susceptibilities in 
pathogens (disc diffusion, broth dilution, and E-test) require large sample volumes, are manually 
intensive, time consuming, and significantly limited in throughput. This poses a considerable risk 
in situations where treatment demands expedient identification of the resistance phenotype of the 
infecting strain.  An approach to counter this challenge is the utilization of integrated 
microfluidic platforms (43, 44, 46) to investigate antibiotic susceptibilities of multi-drug resistant 
pathogens.  Microfluidic approaches offer advantages, including utilization of small reagent 
volumes (viz. antibiotics and patient samples), higher throughput, faster analyses, and are 
amenable to automation.  
 In this work, I describe the design and assembly of a novel microfluidic device to study 
the effects of commonly used antibiotics on E. coli.  I validated the microfluidic platform for 
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biological studies by quantifying the growth dynamics of E. coli cells on-chip.  As a proof-of-
principle experiment, I demonstrated inducible expression of the Green Fluorescent Protein 
(GFP) gene in E. coli cells on-chip using different concentrations of an inducing chemical, 
isopropyl β-D-1-thiogalactopyranoside (IPTG).  Finally, I used the microfluidic platform to 
explore the effects of diverse antibiotics in mediating cell death.  Specifically, I investigated the 
bactericidal and bacteriostatic effects of ampicillin on actively growing E. coli cells.  The 
platform addresses several common issues associated with existing microfluidic devices 
concerning portability, the need for continuous supply of medium, and simplicity of design.   
 
4.2 Design and Fabrication of the Multiplexed Microfluidic Platform 
 Fig. 4.4 shows the design of a modified microfluidic platform from Fig 4.3 (47, 48)  
(loaded with colored dyes) I use in my cell studies.  The modified microfluidic platform (Fig 4.4) 
used in my studies has different shaped chambers (squares) and valves (V-shape) than the 
platform shown in Fig 4.3. Additionally, the device used is a 4x6 microfluidic chip instead of 
4x4 microfluidic chip. This 4x6 microfluidic chip is capable of high throughput screening and 
on-chip mixing within each sub-chamber in a combinatorial format.  The device permits 
controlled exposure of cells in ~2 nL volume compartments to different chemical stimuli loaded 
in contiguous compartments.  The device design is convenient for biological assays due to 
increased detection sensitivity since analysis is performed at a microscale.  Additionally, the 
device facilitates portability and exhibits multiple advantages as a miniaturized biological assay, 
including low sample and reagent volumes for analysis and integration of assay steps in an on-
chip format.  Multiplexing on-chip is achieved by having multiple cell and reagent loading 
compartments on the same device (50). 
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Fig. 4.4.  Optical micrograph of the microfluidic device with different colored dyes showing the contiguous 
cell loading and reagent loading compartments and NC valves for filling and mixing.  The device is 
maintained at a constant temperature of 35 °C using an aluminum block and temperature controller. 
The device is fabricated using standard soft lithographic techniques as discussed in Chapter 2.  
Fig. 4.5 shows a typical experimental set up comprising the microfluidic device resting on an 
aluminum heating block for temperature control (35 °C).  
 
Fig. 4.5.  Typical experimental setup: The 4x6 multiplexed microfluidic device is placed over an aluminum 
heating block to maintain a constant temperature of 35 °C surrounded by 4 medium filled reservoirs.  This 
setup is covered with a coverslip to increase the relative humidity of the environment and minimize 
evaporation.  
 To facilitate long-term experiments, evaporative losses are minimized by placing 
reservoirs filled with Luria-Bertani (LB) medium around the device and affixing a glass slide on 
top of the device, thereby increasing the relative humidity within the assembly.  Imaging is 
performed using an inverted fluorescence microscope (Leica, DMI4000) equipped with an 
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automated stage that can raster the imaging field-of-view between adjacent compartments on the 
device.  All chemicals were purchased from Sigma Aldrich (St. Louis, MO).  
 
4.3 Results and Discussion 
4.3.1 Validation of the Platform for Biological Studies 
 I validated the microfluidic platform for biological studies by studying the growth of  
E. coli cells in the microfluidic chambers.  Wild type E. coli MG1655 cells were transformed to 
express the GFP gene under constitutive control of a lambda phage promoter (51).  Constitutive 
expression of GFP in living cells enables straightforward visualization with fluorescence 
microscopy. 
 I used the multiplexed microfluidic platform to study the growth dynamics of E. coli cells 
in different media (tryptone-yeast extract 2x TY medium, LB medium, and minimal M9 
medium).  The observed on-chip growth dynamics are comparable to bulk growth measurements 
conducted in 96 well-plates (Fig. 4. 6). First, I monitored the growth of bacterial cells in 
microchambers using E. coli constitutively expressing GFP.  Figures  4.7 and 4.8 represent 
quantitative and qualitative analyses of cell growth within a single microchamber.   
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Fig. 4.7.  Growth profiles of E. coli in the microchambers of the 4x6  multiplexed microfluidic platform in 
various media (2x TY, LB, and M9) at 35 °C.   
Fig. 4.6.  Growth profiles of E. coli cells in different nutrient media observed in 96 well plates over a period of 
13 hours. 
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Fig.4.8  Growth profiles of E. coli in the microchambers in (a) 2x TY, (b) LB, and (c) M9 media at 35 °C  
 Quantitative analysis using ImageJ for growth of E. coli cells yielded doubling times of 
35, 54, and 165 minutes for 2x TY, LB, and M9 media, respectively.  Fig. 4.7 shows growth of E. 
coli quantified as rate of increase in total cell area. Similar analyses were also performed using 
fluorescence intensity and total number of cells to quantify cell growth (Chapter 7).  Since cell 
area yielded the most compatible results in accordance with the methodology of my analysis, I 
used cell area to quantify growth in subsequent experiments.  
 
4.3.2 Distribution of Chamber Wise Cell Loading Density 
 Cellular dynamics (growth, death, gene expression, cell-cell communication) in confined 
microenvironments are strongly affected by their population densities (52). As an example, if the 
initial cell density is high for a particular chamber, the cells in that chamber reach the log phase 
of growth faster than cells in  chambers with lower densities (43).  Likewise, since antibiotics are 
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generally more effective in killing sparse cell populations vis-à-vis denser populations, it 
becomes crucial to quantify chamber-to-chamber variations in cell density.  Fig. 4.9 represents 
initial loading densities normalized to the maximum cell area or cell number in a particular 
chamber for the entire device. Fig. 4.10 represents initial loading densities normalized to the 
maximum cell area or cell number for the two individual control lines used for loading cells and 
reagents.  The darkest chamber represents the densest chamber.  
 
 
Fig. 4.9.  Overall average initial cell loading density of E. coli cells by (a) cell number and (b) cell area for 
3 devices normalized to the maximum for the entire device. 
 
 
Fig. 4.10.  Average initial cell loading density of E. coli cells by (a) cell number and (b) cell area 
normalized to the maximum for horizontal and vertical lines separately. 
 
 The initial loading densities as we see from Figures 4.9 and 4.10 appear random.  
Therefore, one of the limitations associated with the device is that controlled distribution of cells 
(a) (b)
(a) (b)
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in multiple microchambers is not possible.  However, this does not impact data analysis since 
cell numbers and areas in microchambers are normalized to initial loading densities. Initial 
loading densities for the three individual devices are depicted in Chapter 7.  
 
4.3.3 Proof-of-principle: On-chip Gene Expression in E. coli Cells 
E. coli exhibits switch-like dynamics in the expression of certain genes, as is typified by 
the IPTG-inducible expression of the lac operon.  Switch like behavior leads to bimodal 
distribution in cell population wherein induced cells exhibit considerably enhanced expression 
levels of a gene with respect to uninduced cells  (53). 
As a proof-of-principle experiment, I have demonstrated inducible expression of the GFP 
gene in E. coli cells on-chip using different concentrations of IPTG (Fig. 4.11).  For gene 
expression experiments, E. coli cells were transformed to express the GFP gene from the IPTG-
inducible lac promoter.  Cells and chemical reagents are first loaded into the device by actuating 
the filling valves using a vacuum pump.  Next, cells and chemicals (IPTG) are allowed to mix by 
repeatedly actuation of the mixing valve for ~20 minutes.  Six different concentrations of IPTG 
were loaded into adjacent microchannels in the device, and I monitored cell growth and 
fluorescence emission.  Fig. 4.11 shows expression of GFP in cells after addition of IPTG to an 
initially uninduced (non-fluorescent) cell population.  Expression of the GFP gene results in 
increasing cellular fluorescence and is observed within ~0.6 h of IPTG addition, peaking at ~6 h.  
The use of NC valves permits leak-free isolation of IPTG and cells in their lag-phase of growth, 
thereby enabling precisely controlled exposure of cells during exponential growth when protein 
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expression is optimal.  
 
Fig. 4.11.  On-chip IPTG induced GFP expression in E. coli cells.  Uninduced cells (non-fluorescent) and 
IPTG (2 mM) are mixed at t = 0 and imaged for 6 hours during which the initially uninduced population 
begins expressing GFP and fluorescing. 
 
4.3.4 Effect of Various Antibiotics on E. coli Cells in Bulk 
 Antibiotic screening in bulk is usually performed using 96 well plates.  The changes in 
cell number are usually recorded using absorbance spectroscopy over several hours.  This 
method is convenient when one requires ensemble averages data.  However, since certain 
antibiotics are known to cause morphological changes, which are impossible to discern in bulk.  
Hence, getting information about individual cells is challenging at bulk scale.  I studied the effect 
of two bactericidal (causing cell death) antibiotics: ampicillin, ciprofloxacin, and two 
bacteriostatic (causing stagnation of cell growth) antibiotics: tetracycline and erythromycin on 
growing E. coli cells in bulk.  Fig. 4.12 (a) shows the bactericidal effects of ampicillin and 
ciprofloxacin on growing E. coli cells.  Cell growth occurs at low concentrations (0.1 µg/mL and 
1 µg/mL) of ampicillin, and cell death occurs at higher concentrations.  We see sudden jumps of 
data points at 10 µg/mL. This is not observed in bulk studies because ampicillin causes 
morphological changes that are not quantifiable by absorbance measurements employed by bulk 
analyses.  Similarly, since ciprofloxacin is also known to cause morphological changes to the 
cells, we are unable to identify similar phenotypes in the bulk scale.  However, at higher 
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concentrations (>1 µg/mL of ciprofloxacin), cells tend to die.  Fig. 4.12 (b) shows the 
bacteriostatic effects of erythromycin and tetracycline antibiotics on growing E. coli cells.  Cell 
death commences only at high concentrations for erythromycin (>100 µg/mL) and tetracycline 
(> 1µg/mL).   
 
Fig. 4.12.  (a) Effect of bactericidal (ampicillin & ciprofloxacin) and (b) bacteriostatic (erythromycin & 
tetracycline) antibiotics on growing E. coli cells.  
 
4.3.5 On-chip Effect of the Antibiotic Ampicillin on E. coli Cells 
 I have extended on-chip screening experiments to elucidate morphological changes 
associated with bacterial response to ampicillin.  Fig. 4.13 shows the morphological changes in E. 
coli cells upon treatment with 100 μg/mL of ampicillin.  The antibiotic ampicillin first arrest cell 
(a) 
(b) 
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growth and induces a filamentous morphology in cells due to an inhibition of cell wall assembly.  
Massive cell lysis and death occur within 12 hours of antibiotic treatment.  Fig. 4.14 quantifies 
the bactericidal effects of ampicillin on growing E. coli cells.  
 
Fig. 4.13.  Effect of ampicillin on growing E. coli cells on-chip. Treatment with ampicillin at 100 µg/mL 
initially induces cell filamentation (t=5 h, 6.25 h) and subsequently leads to massive cell lysis and death 
(t= 12 h). Images are pseudo-colored in Matlab. 
 
 From Fig. 4.14, at lower concentrations (1 µg/mL, 10 µg/mL) of ampicillin, even though 
cell death is not conspicuous, I observe filamentation of cells at 10 µg/mL.  However, at higher 
concentrations of the antibiotic (≥ 100 µg/mL), massive cell death occurs.  Consequently, 
Minimum Inhibitory Concentration (MIC) for ampicillin on-chip lies between 10 and 100 µg/mL.  
Bulk studies indicate the MIC for ampicillin against E. coli to be 32 µg/mL (54).  This value is 
comparable to the value obtained on-chip. 
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Fig. 4.14.  Effect of the antibiotic ampicillin on growing E. coli cells on-chip at 35 °C.  Ampicillin is 
ineffective at a concentration of 1 µg/mL 
 
4.4 Conclusions 
 In conclusion, I have validated a 4x6 multiplexed microfluidic device utilizing optimized 
normally closed microfluidic valves for biological studies by initially analyzing the growth 
dynamics of E. coli cells in the microchambers of the device.  As a proof-of-principle experiment 
to test the multiplexing capabilities, I have assayed GFP gene expression with on-chip mixing of 
cells and an inducing chemical, IPTG.  Additionally, I have utilized the microfluidic platform for 
antibiotic screening using E. coli.  In particular, I have quantified growth inhibition profiles of 
bacterial cells stressed with the bactericidal antibiotic ampicillin.  Presently, I am studying 
synergistic effects of different antibiotic combinations on pathogens using the microfluidic 
platform. 
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Chapter 5 
Concluding Remarks 
5.1 Summary 
In this Master’s thesis, I report a systematic study of the design, fabrication, optimization, 
operation, and application of normally closed (NC) valves in integrated microfluidic networks.  
Pneumatic NC valves are increasingly being used in microfluidic devices because they not only 
retain the salient features of the currently more prevalent normally open pneumatic valves 
(simple fabrication and integration), but also improve portability of the devices, since NC valves 
are closed at rest, and thus do not require continuous actuation during chemical or biological 
experiments.  I conducted a systematic experimental study on NC valves where I investigated the 
effect of various parameters on the actuation pressures and operational reliability, including 
channel width, asymmetry (valve geometry and position of the valve stop), and membrane 
thickness.  I observed that channel width and membrane thickness do not significantly influence 
the actuation pressures, while introducing valve asymmetry (i.e., the location of weak points of 
adhesion) led to a stronger correlation with actuation pressure.  Based on my observations, I 
showed that the adhesion properties of the valve with the substrate have a stronger influence on 
the actuation pressure than the mechanical properties of the valve membrane.  I also 
demonstrated that the ability of the NC valves to actuate at lower pressures is crucial in dense 
microfluidic networks, in which multiple valves are typically linked in series.  Based on my 
experimental results and theoretical analysis, I formulated a set of design rules that will guide the 
design of complex microfluidic networks with NC valves that actuate reliably at low pressures.  
These design rules for NC valves will benefit their increased use in a wide range of microfluidic 
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applications, especially for those where portability is important.  Furthermore, the fact that NC 
valves require actuation only for filling of a microfluidic device after which all ancillaries can be 
disconnected, benefits those applications that involve subsequent on-chip analysis of the 
chemical or biological processes in confined spaces (e.g., fluorescence or Raman microscopy, IR, 
X-ray). 
I used the optimized design rules to fabricate a multiplexed microfluidic platform for 
biological studies.  I specifically analyzed the growth dynamics of E. coli cells, assaying GFP 
gene expression with on-chip mixing of cells and inducer, and quantifying growth retardation 
profiles of cells stressed with ampicillin.  These studies will benefit diagnostic testing 
applications in clinical settings. 
 
5.2 Future Work 
I am currently employing the multiplexed 4x6 array microfluidic platform to develop 
optimal treatment regimens for diverse antibiotic-pathogen combinations.  The purpose behind 
this biological screening is that in my future studies, I want to suggest an optimal strategy to 
suppress multi-drug resistance in bacterial cells; consequently, my future aim is to suppress the 
evolution of multi-drug resistance.   
Subsequently, I will test the effect of diverse single antibiotics at various ranges of 
concentrations on bacterial cells.  The key goal will be to investigate synergistic effects of 
antibiotics against E. coli (a model system) and pathogens such as Pseudomonas aeruginosa (a 
model system for MRSA outbreaks in clinics) and eventually screen actual clinical isolates such 
as infected human blood for antibiotic susceptibility.  
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Additionally, I hope to use the microfluidic array chip to investigate microbial gene 
expression, and extend these studies to the single cell level.  Specifically, I will use the growth 
dynamics of E. coli to study the phenomenon of bistability in gene expression in the bacterial 
lactose metabolism network.  Consequently, the goal will be to extend these experiments to 
elucidate multi-stable gene expression profiles that are associated with bacterial responses to 
diverse metabolites such as hormones and toxins for diagnostic testing. 
  
56 
 
Appendix A 
A.1 Analytical Model for Optimization of Normally Closed Valves 
A.1.1 Derivation of Scaling Laws for Actuation Pressures   
 
Fig. A.1.  Schematic illustration of top and side views of the normally closed microvalve. 
In Fig. A.1, the membrane (thinner portion of the valve) is indicated by hatched lines.  
We model the valve opening as peeling of the valve stop by forces exerted along edges of the 
valve stop.  Peeling will be prominent along the three edges of the membrane in contact with the 
valve stop.  First, we derive a relation between forces along the membrane edges and applied or 
actuation pressure (papp).  The applied pressure deflects both the membranes upwards, which in 
turn applies load (peeling forces) on the valve through the membrane edges.  If edgeF is the force 
per unit length exerted by the membrane edges due to the applied pressure, then by force balance 
 wL
wLpF
pF
appedge
appedge


0
08
area membraneperimeter membrane
 (1) 
where 2L0 = L1 + L2, and we have considered both the membranes.  The above equation and the 
scaling relations derived subsequently are valid if L2 is replaced by L1.  The forces exerted by the 
57 
 
membrane edges are used to bend the valve upwards (Fbend) and overcome the adhesion force 
between PDMS and glass by peeling (Fpeel).  Therefore, 
 width adhesion  ofwork 
(length)
)(thickness  width  modulus
3
3


peel
bend
F
F
. (2) 
The equation for scaling of bending or membrane deflection forces is based on standard theory 
of beam mechanics, while the peeling force scaling is based on peeling mechanics of rectangular 
adhesive strips (1, 2) 
Our experimental results on dependence of actuation pressures on fluid channel width 
and membrane thickness indicate that peeling of PDMS valve stop is the dominant mechanism 
for valve actuation.  Since the valve peeling of primary interest is along edge with length w, 
wFpeel   , (3) 
where γ is the work of adhesion between PDMS and glass.  The peeling force can be also 
represented in terms of membrane edge forces ( edgeF ), and hence the applied pressure (papp) as  
 wL
wLpFwFF apppeeledgepeel  0
2
0
8
. (4) 
Combining Eq. (3) and (4), we arrive at the scaling relation for actuation pressure as 
wL
papp
11
0
 . (5) 
Note that L0 was maintained constant for all the experiments. 
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Alternatively, we can model the valve actuation as pulling apart a PDMS block from a 
glass substrate, where the actuation pressure is required to overcome the adhesive forces between 
the PDMS and glass.  In this case, the adhesive force is proportional to area of valve contact with 
the glass, and hence the actuation pressure can be approximately represented as 
  


 

cc
ccapp
app
L
w
L
LLLwLLLp
p
212
21
2 1
contact of area 
. (6) 
Since Lc and L1+L2 were maintained constant for all valve configurations, Eq. (6) simplifies to 
the scaling relation of Eq. (7).  
c
app L
wp 1 . (7) 
A.1.2 Modeling Influence of Geometrical Parameters on Valve Actuation  
To understand the influence of geometrical asymmetry on actuation pressures, we model 
the actuation as peeling of the valve stop off the glass substrate, since peeling is the dominant 
mechanism of deformation.  This peeling, in turn, can be modeled as propagation of a crack by 
initiation of the crack at the PDMS-glass interface, where the valve stop contacts the glass 
substrate.  This crack will initiate in the region where the contact stresses are maximum or most 
concentrated, when actuation pressure is applied on the valve area. 
To estimate these contact stresses in the valve stop, we simulate valve deformation using 
ANSYS, a commercially available finite element analysis (FEA) software.  An example model 
of a v-shaped valve is shown in Fig. A.2, where the contour plots for valve deformation in 
vertical direction is calculated.  Once the valve deformation is simulated, we estimate von mises 
stresses or equivalent contact stresses along edges of the valve stop that contact the glass 
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substrate.  For instance, edges of the valve stop contacting the substrate are shown in Fig. A.4 for 
a v-shape valve in form of a path.   
 
Fig. A.2.  ANSYS simulation showing contour plots for vertical deformation of a v-shaped valve subjected 
to uniform actuation pressure in the vertically upward direction (negative Z direction in figure). 
We estimate the contact stresses as described above, and plot variation in these stresses as 
the path shown in Fig. A.3 is traversed.  In Fig.A.4, the variation in contact stresses for valves 
with similar dimensions but different shapes (straight, v-shape, diagonal) is plotted as a function 
of path traverse.  The applied negative pressure was approximately 2 psi.  From Fig. A.4, the 
stresses are more concentrated at the center for v-shaped valve compared to straight.  As a result 
of higher stress concentration, the crack can be more easily initiated at the center for v-shaped 
valve, which leads to easier peeling of the valve stop, and consequently lower actuation pressures.  
Based on the above argument, the actuation pressures for diagonal valve will be the highest, 
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since the stresses are least concentrated at the center.  In fact, the stresses are highly concentrated 
at the corner feature of the diagonal valve (P1), which is not convenient for peeling or valve 
actuation.  Hence, the asymmetry in the valve design should be such that contact stresses are 
concentrated at the center, which will require minimal peeling forces at the center, and 
consequently lower actuation pressures. 
 
Fig A.3.  Edges of the valve stop for a v-shaped valve contacting the glass substrate.  Von mises 
stresses are estimated along the path as shown. 
We similarly plot the variation in contact stresses for v-shaped valve with different 
asymmetry ratios in Fig. A.5.  From the stress variation plot, we conclude that increasing 
asymmetry in v-shaped valve leads to reduced stress concentration at the center, and hence, 
higher actuation pressures.  This conclusion is consistent with our experimental observations. 
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Fig A.4.  Von mises contact stresses as a function of path traverse for three different shapes of the valve 
stop. 
 
 
Fig A.5.  Von mises contact stresses as a function of path traverse for v-shaped valves with different 
asymmetry ratios. 
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A.1.3 Optical Micrographs Illustrating Valve Opening for Asymmetric Valves 
In Fig. A.6, we show optical micrographs of actuation for an asymmetric straight valve, 
where L1:L2 is 5:1.  In Fig. A.6a, the valve stop is partially lifted off the substrate, and two 
contact lines form.  Since none of the contact lines link the two opposite edges of the valve stop, 
we assume that fluid cannot flow, and the valve is not completely open.  On increasing the 
actuation pressure (Fig. A.6b), the outer contact line becomes larger, and links the two opposite 
edges of the valve stop.  At this point, we define the valve as completely open, and the pressure 
at this instant as actuation pressure.  Since the valve opening configuration depends on the valve 
geometry, we define the valve as completely open, when at least one of the contact lines links the 
two opposite edges, rather than when we observe the formation of contact lines. 
 
Fig A.6.  Optical micrographs showing actuation of an asymmetric straight valve, where L1:L2 is 5:1. 
A.1.4 Actuation of Arrays of Normally Closed Valves 
Fig. A.7a shows a schematic illustration of the device comprising an array of 44 valves.  
The overall size of the chip was 4.5 cm by 4.5 cm.  An image of the actual device with magnified 
view of one of the valves is shown in Fig. A.7b. 
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Fig A.7.  (a) Schematic illustration of a device with 44 valves connected serially by a single control line.  
This schematic shows ‘straight’ valves, but we also tested v-shaped valves. (b) Image of the actual device 
with magnified view of one of the valves. 
A.1.5 Application of Normally Closed Valves for Mixing Solutions 
To validate the application of NC valves for manipulating liquids, we fabricated a 
microfluidic platform employing straight and v-shaped valves, as shown in Fig. A.8.  The PDMS 
device was reversibly bonded to a glass substrate.  Dyed aqueous solutions were filled into the 
chambers by actuating or opening the v-shaped NC valves on the vertical lines.  During filling, 
the straight NC valves linking the two chambers were closed.  Once the chambers were 
completely filled, the v-shaped valves were closed and the straight valves were opened.  At this 
point, the solutions in the two chambers began to mix by diffusion.  This application 
demonstrates that the valves can block fluid flow in the closed state, as evident by absence of 
liquids in the region of the valve stop for v-shaped valves (Fig. A.8).  
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Fig. A.8.  Microfluidic platform demonstrating application of NC valves to manipulate liquids.  Each 
chamber is 600 μm wide.  The absence of liquids in the region of the valve stop for v-shaped valves 
demonstrates that the valves can block fluid flow.  
A.1.6 Design Rules Modification when the Membrane Deflection Forces Dominate 
In the cases where the bending or membrane deflection forces dominate, the actuation 
pressure will be primarily governed by the stiffness of the valve, which includes the membrane 
and the valve stop.  Higher valve stiffness will lead to higher actuation pressures.  An accurate 
estimate of the valve stiffness will require finite element analysis (FEA) simulations.  However, 
an approximate estimate of the stiffness can be obtained by treating the valve as a thick square 
membrane with side length as Lc and thickness (tv) as hf + t, where Lc is the total length of one 
side of the valve, hf is the fluid channel height, and t is the membrane thickness (Fig. 2.1).  Then, 
the valve stiffness is mainly a function of Lc and tv. 
When we vary the shape of the valve stop, the valve area with lower thickness (t) relative 
to the total valve area with higher thickness (tv) is almost the same, and hence, the valve stiffness 
is almost similar.  To support this claim, we estimated the overall valve stiffness using ANSYS, 
commercially available FEA software, by computing the valve deformation subjected to uniform 
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pressure.  We observed that the variation in values of valve stiffness for the three shapes was 
within 3%. 
When we introduce asymmetry by displacing the valve stop, the central region of the 
valve is thinner compared to a symmetric valve (t instead of tv).  However, the valve area with 
lower thickness (t) relative to the total valve area is still the same.  Hence, we expect the valve 
stiffness to decrease slightly with increasing asymmetry.  From our FEA simulations, we 
observed that the valve asymmetry led to 9% reduction in valve stiffness for straight valves, and 
5% reduction for v-shaped valves. 
When we increase the width of the valve, the valve area with lower thickness increases, 
and hence the valve stiffness will decrease.  We also observed this decrease in valve stiffness 
with increasing width in our FEA simulations. 
Finally, as the membrane thickness decreases, the local stiffness of the valve area with 
lower thickness decreases, and hence the overall valve stiffness decreases.  This fact is evident in 
our data on the influence of membrane thickness on actuation pressures (Fig. 3.1), where the 
experiments were performed without any substrate.  When a substrate is not used, adhesion 
forces are absent, and the actuation pressures are determined by the valve stiffness only. 
In summary, if bending or membrane deflection forces dominate, then the actuation 
pressures are not significantly influenced by shape of the valve stop and asymmetry in position 
of the valve stop.  However, the actuation pressures will increase with decreasing fluid channel 
width and increasing membrane thickness.  
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Appendix B 
B.1Quantitative Methods Used for Counting Cells 
Figuring out the number of cells in each image is a common requirement in many image 
analysis techniques.  Three different kinds of approaches were used to count the number of cells 
in a sequence of images overtime.  
B.1.1Cell Number 
As the name suggests, this approach counts the number of pixels in each image where 
each pixel corresponds to a cell.  This is an ideal way to count the number of cells for sparse 
chambers.  However, if the density of a chamber is high, or multiple cells are touching each other, 
then this approach fails, because cells that are stuck together are counted as one entity.  In reality, 
this entity is a combination of multiple cells.  For example – Fig.B.1 shows growth rate of E. coli 
in different media (2x TY, LB, M9) where I have used cell number as the approach to analyze 
the data.  For very rich media (2x TY), the cell count decreases after about 5 hours of growth, 
which in reality is not true because the chambers are extremely dense, and get denser with time.  
A similar trend is seen with LB (rich medium) but after about 6 hours since the nutrients for 
growth are lesser than 2x TY.  The result looks good with M9 (poor) medium, since the cell 
growth in this medium is not that high and cells are not stuck together even after 12 hours of 
growth.  Multiple experiments were done to confirm this trend.   
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Fig. B.1  Growth rate of E. coli where image analysis is done using cell number in ImageJ 
 
 
B.1.2 Cell Area 
An approach to resolve the issue faced for dense chambers is to utilize the method of cell 
area instead of cell count.  In this method, imageJ calculated the area covered by the pixels in 
each chamber instead of counting each pixel as a cell. Hence, as the cell count increases, the cell 
area increases with no contradictions between cell analysis results and actual images.  Fig. 4.6 
shows an example of analysis performed via cell area.  
B.1.3 Fluorescent Intensity 
Fluorescent intensity was used initially for data analysis since this method has been a 
widely used method for this purpose.  This method models spatial brightness distribution, and 
photon distribution (1).  Brighter image will give a higher number relative to an image, which is 
not as bright.  One of the biggest challenges of using this method is the fluorescent intensity 
fluctuations caused due to random movement of fluorescent molecules.  Since there were many 
fluctuations in my data with fluorescent intensity as the analysis method, I did not use this 
method in any of my analysis.  Fluctuations in fluorescent intensity can be attributed to the fact 
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that the automated focus of the chambers slightly varied when the experiments were left 
unattended overnight.  
B.1.4 Effect of Poly-Lysine (PLL) on Quantitative Analysis 
PLL coating was initially used on glass coverslip to prevent movement of bacterial cells 
in the z-direction which would cause the cells going out of focus.  Cells of different kinds adhere 
firmly to glass which have been pretreated with PLL (2).  This seemed initially necessary for my 
experiments because the movement of cells in the z direction caused several microscope focus 
issues.  Although, the bacterial cells adhered well to the glass surface, PLL coating did not 
provide reasonable and reliable results.  This inconsistency can be attributed to the fact that PLL 
sometimes causes morphological changes to the bacterial cells.  Additionally  PLL coating 
causes considerable cell-to-cell variability in many bacterial cells (3).  Hence, I decided to 
modify the device design by making the chambers of the platform shallower, reducing the height 
from 25 µm to 15 µm.  This modification resolved the issue of the movement of cells in the z-
direction.  With the shallower channels, cells in the whole the channel can be captured, because 
the depth of focus of the microscope exceeds the channel height.   
 
B.2 Device Images 
B.2.1 Initial Device Design 
Initially, the device design consisted of straight shaped NC valves (Fig. B.2).  These 
valves sometimes presented actuation issues in dense networks.  Hence, using the design rules 
(from Chapter 3), I replaced all the valves to v-shaped valves (Fig. 4.4).  This modification led to 
easy and reliable actuation of the valves consistently. 
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Fig B.2.  Initial device design with straight shaped normally closed valves 
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